Price$23.11-5.31 (-18.68%)
2026-03-042026-06-05
News · 26 weeks44+200%
2025-12-142026-06-07
Mix2390d
- Insider8(35%)
- SEC Filings6(26%)
- Other5(22%)
- Market2(9%)
- Earnings1(4%)
- Analyst1(4%)
Latest news
25 items- SECEnvista Holdings Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Envista Holdings Corp (0001757073) (Filer)
- SECSEC Form SD filed by Envista Holdings CorporationSD - Envista Holdings Corp (0001757073) (Filer)
- INSIDERChief Executive Officer Keel Paul A covered exercise/tax liability with 12,811 shares, decreasing direct ownership by 3% to 371,574 units (SEC Form 4) to satisfy tax liability4 - Envista Holdings Corp (0001757073) (Issuer)
- PRHenry Schein Announces the Election of William K. "Dan" Daniel as Independent Chairman of the BoardHenry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected William K. "Dan" Daniel as Independent Chairman of the Board, effective May 21, 2026. Mr. Daniel succeeds Stanley M. Bergman, who retired from the Board following 44 years as a Director of Henry Schein and was named Chairman Emeritus in recognition of his extraordinary contributions to the Company. Mr. Daniel joined the Henry Schein Board of Directors in May 2025. He possesses decades of board and global executive leadership experience in healthcare and industrial sectors, including serving for 14
- INSIDERDirector Tsingos Christine A was granted 9,330 shares, increasing direct ownership by 18% to 59,930 units (SEC Form 4)4 - Envista Holdings Corp (0001757073) (Issuer)
- INSIDERDirector Carruthers Wendy was granted 9,330 shares, increasing direct ownership by 18% to 59,940 units (SEC Form 4)4 - Envista Holdings Corp (0001757073) (Issuer)
- INSIDERDirector Raskas Daniel was granted 9,330 shares, increasing direct ownership by 21% to 54,010 units (SEC Form 4)4 - Envista Holdings Corp (0001757073) (Issuer)
- INSIDERDirector Huennekens R Scott was granted 12,585 shares, increasing direct ownership by 18% to 82,105 units (SEC Form 4)4 - Envista Holdings Corp (0001757073) (Issuer)
- INSIDERDirector Pierce James Andrew was granted 9,330 shares, increasing direct ownership by 102% to 18,485 units (SEC Form 4)4 - Envista Holdings Corp (0001757073) (Issuer)
- INSIDERDirector Gallahue Kieran was granted 9,330 shares, increasing direct ownership by 21% to 54,010 units (SEC Form 4)4 - Envista Holdings Corp (0001757073) (Issuer)
- INSIDERDirector Jain Vivek was granted 9,330 shares, increasing direct ownership by 21% to 52,945 units (SEC Form 4)4 - Envista Holdings Corp (0001757073) (Issuer)
- SECEnvista Holdings Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Envista Holdings Corp (0001757073) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Envista Holdings CorporationSCHEDULE 13G/A - Envista Holdings Corp (0001757073) (Subject)
- SECSEC Form 10-Q filed by Envista Holdings Corporation10-Q - Envista Holdings Corp (0001757073) (Filer)
- SECEnvista Holdings Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Envista Holdings Corp (0001757073) (Filer)
- PRCooperCompanies Appoints Paul Keel to its Board of DirectorsSAN RAMON, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, announced today that its Board of Directors has appointed Paul Keel as an independent director, effective July 1, 2026. Mr. Keel has also been appointed to serve on the Audit Committee when he joins the Board. "We are delighted to welcome Paul to our Board as a new Director," said Colleen Jay, Chair of the Board of CooperCompanies. "His experience as a CEO in the medical device sector, along with a successful track record of leading complex global operations, will be a significant asset as Cooper continues to execute its strategy and create long-term value for patient
- NEWSGreater Canal Efficiency. Less Waste. Introducing ZenSeal(TM) Pro with ZenSave(TM) Tips from Kerr DentalBREA, CA / ACCESS Newswire / April 16, 2026 / Kerr Dental announced the launch of NEW ZenSeal Pro with ZenSave Tips, an innovative advancement in bioceramic (BC) sealer delivery, engineered to help clinicians treat more canals with every syringe, while maintaining the high performance and clinical confidence they expect.Building on the trusted performance of ZenSeal™ Plus BC sealer, ZenSeal Pro takes efficiency and handling even further-so if you love ZenSeal, you'll love ZenSeal Pro even more.Featuring the low-waste ZenSave Tips, ZenSeal Pro reduces material waste by 33.5% compared to other high-flow bioceramic sealers, enabling practices to maximize value without compromising obturation qu
- NEWSKerr Dental Launches Demi(TM) Pro - The Light That Moves With YouAn Ergonomic Curing Light Built for Comfort, 360° Access, Deeper Cures, and SafetyBREA, CA / ACCESS Newswire / April 16, 2026 / Kerr Dental announces the launch of Demi Pro, a new cordless curing light designed to deliver dependable, uniform curing performance with reduced fatigue and improved access - even in challenging anatomies. Engineered for both dentists and dental assistants, Demi Pro supports modern restorative workflows through a balance of ergonomics, optical performance, and intuitive safety features.Ergonomics: Built for All-Day ComfortDemi Pro features a lightweight, balanced aluminum body with a pen-style grip that helps reduce hand strain during repetitive procedures. Interna
- ANALYSTCitigroup initiated coverage on Envista with a new price targetCitigroup initiated coverage of Envista with a rating of Neutral and set a new price target of $29.00
- PREnvista Schedules First Quarter 2026 Earnings CallBREA, Calif., April 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its first quarter 2026 on Wednesday, May 6, 2026. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour. The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You can
- SECSEC Form DEFA14A filed by Envista Holdings CorporationDEFA14A - Envista Holdings Corp (0001757073) (Filer)
- SECSEC Form DEF 14A filed by Envista Holdings CorporationDEF 14A - Envista Holdings Corp (0001757073) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Envista Holdings CorporationSCHEDULE 13G/A - Envista Holdings Corp (0001757073) (Subject)
- INSIDERGeneral Counsel Nance Mark E covered exercise/tax liability with 3,368 shares and was granted 12,675 shares, increasing direct ownership by 13% to 81,252 units (SEC Form 4)4 - Envista Holdings Corp (0001757073) (Issuer)
- INSIDERSVP, Strategy & Bus. Dev. Reis Mischa covered exercise/tax liability with 2,976 shares and was granted 5,915 shares, increasing direct ownership by 9% to 35,321 units (SEC Form 4)4 - Envista Holdings Corp (0001757073) (Issuer)
NVST FAQ
7 questionsWhat does Envista Holdings Corporation do?
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera...Where does NVST stock trade?
Envista Holdings Corporation (NVST) is listed on NYSE.What sector and industry is NVST in?
Envista Holdings Corporation operates in the Health Care sector, Medical/Dental Instruments industry.When did Envista Holdings Corporation go public?
Envista Holdings Corporation (NVST) completed its IPO in 2019.What are analysts saying about NVST?
Envista Holdings Corporation has had 8 recent analyst actions on file. The most recent action was from Citigroup: Neutral with a $2900.00 price target on 2026-04-15. Recent price targets range from $1600.00 to $3500.00.What companies are similar to NVST?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare NVST side-by-side with any of them on Quantisnow.How can I track NVST on Quantisnow?
Quantisnow aggregates Envista Holdings Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NVST to receive live email and push alerts on every new disclosure.